Simplification to Single Tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, Tenofovir DF from Multi-tablet Ritonavir-Boosted Protease Inhibitor Plus Coformulated Emtricitabine and Tenofovir DF Regimens: Week 96 Results of STRATEGY-PI. HIV Clinical Trials 18-03 (2017).
https://doi.org/10.1080/15284336.2017.1330440
We the authors wish to clarify that Dr. Manuela Doroana, MD, was the STRATEGY-PI investigator at the Hospital de Santa Maria in Lisbon, Portugal, from January 2012 until the conclusion of the study in April 2015. During this time period, Dr. Doroana was responsible for enrolment and data collection on all study subjects at this site. Prior to the publication of this manuscript, Dr. Doroana retired from clinical practice, and is no longer affiliated with the Hospital de Santa Maria.